ADIPOQ and carotid atherosclerosis: Since adiponectin has insulin-sensitizing, anti-inflammatory and anti-atherogenic properties, low plasma levels of adiponectin can be therefore independent predictors of IHD, and platelet activation in carotid atherosclerosis both in diabetic and non-diabetic subjects [38–41].